ConductScience.org, home

Paper37830006

The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations.

Selker HP and 4 others. J Clin Transl Sci, 2023. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations. Papers, record 37830006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37830006

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations.
PubMed
Journal
J Clin Transl Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2024-09-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Selker HPHarry Phttps://orcid.org/0000-0001-5322-7178
2Dulko DDorothyhttps://orcid.org/0000-0003-0274-1657
3Greenblatt DJDavid J
4Palm MMarishahttps://orcid.org/0000-0002-9760-7196
5Trinquart LLudovic

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127376097Appreciating the Nuance of Daily Symptom Variation to Individualize Patient Care.EGEMS (Wash DC)2016https://conductscience.org/library/papers/27376097PubMed
234642487Individualized therapy trials: navigating patient care, research goals and ethics.Nat Med2021https://conductscience.org/library/papers/34642487PubMed
336863730Replacing RCTs with real world data for regulatory decision making: a self-fulfilling prophecy?BMJ2023https://conductscience.org/library/papers/36863730PubMed
431698713N-of-1 Trials as a Decision Support Tool in Clinical Practice: A Protocol for a Systematic Literature Review and Narrative Synthesis.Healthcare (Basel)2019https://conductscience.org/library/papers/31698713PubMed
538009129Conduct and Implementation of Personalized Trials in Research and Practice.Harv Data Sci Rev2022https://conductscience.org/library/papers/38009129PubMed
631597037Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease.N Engl J Med2019https://conductscience.org/library/papers/31597037PubMed
79179098Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment.J Clin Epidemiol1997https://conductscience.org/library/papers/9179098PubMed
88133588Randomized clinical trials in single patients during a 2-year period.JAMA1993https://conductscience.org/library/papers/8133588PubMed
931754660Making the switch: From case studies to N-of-1 trials.Epilepsy Behav Rep2019https://conductscience.org/library/papers/31754660PubMed
1030193253Effect of Mobile Device-Supported Single-Patient Multi-crossover Trials on Treatment of Chronic Musculoskeletal Pain: A Randomized Clinical Trial.JAMA Intern Med2018https://conductscience.org/library/papers/30193253PubMed
1128902570Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy.N Engl J Med2017https://conductscience.org/library/papers/28902570PubMed
1236605403An approach to data collection in compassionate use/managed access.Front Pharmacol2022https://conductscience.org/library/papers/36605403PubMed
1337706004Applying real-world data from expanded-access ("compassionate use") patients to drug development.J Clin Transl Sci2023https://conductscience.org/library/papers/37706004PubMed
1431570318The future of cystic fibrosis care: a global perspective.Lancet Respir Med2020https://conductscience.org/library/papers/31570318PubMed
1520863658Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations.J Clin Epidemiol2010https://conductscience.org/library/papers/20863658PubMed
1634551122A Useful and Sustainable Role for N-of-1 Trials in the Healthcare Ecosystem.Clin Pharmacol Ther2022https://conductscience.org/library/papers/34551122PubMed
179925061Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice.Chest1999https://conductscience.org/library/papers/9925061PubMed
1834797920Real-World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value.Clin Pharmacol Ther2022https://conductscience.org/library/papers/34797920PubMed
1917014022Lessons learned combining N-of-1 trials to assess fibromyalgia therapies.J Rheumatol2006https://conductscience.org/library/papers/17014022PubMed
2027107878N-of-1 trials can be aggregated to generate group mean treatment effects: a systematic review and meta-analysis.J Clin Epidemiol2016https://conductscience.org/library/papers/27107878PubMed

Download CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42729723Establishing Core Outcome Sets to Advance Evidence Synthesis in Behavior Analysis.Perspect Behav Sci2026https://conductscience.org/library/papers/42729723PubMed
42596576Strengthening Rural Health With N-of-1 Trials and Single-Case Experimental Designs.Aust J Rural Health2026https://conductscience.org/library/papers/42596576PubMed
41872601Five tenets for advancing evidence-based precision medicine.Nat Med2026https://conductscience.org/library/papers/41872601PubMed
41590516Randomized Personalized Trial for Stress Management Compared to Standard of Care.J Pers Med2026https://conductscience.org/library/papers/41590516PubMed
41459511Conceptual quantitative systems pharmacology framework for supporting clinical trial design in organ-specific autoimmune and rare diseases.Front Immunol2025https://conductscience.org/library/papers/41459511PubMed
41355573N-of-1 trials in clinical research: Methodological foundations, statistical approaches and implementation challenges.Br J Clin Pharmacol2026https://conductscience.org/library/papers/41355573PubMed
41122189The N-of-1 Trials and where to use them in Rheumatology.Mediterr J Rheumatol2025https://conductscience.org/library/papers/41122189PubMed
41113758Drug Development for Pulmonary Arterial Hypertension: Unleashing the Potential of Single-Patient Studies Using Continuous Monitoring.Pulm Circ2025https://conductscience.org/library/papers/41113758PubMed
40447582From precision interventions to precision health.Nat Commun2025https://conductscience.org/library/papers/40447582PubMed
40176845Beyond p-values: a cross-sectional umbrella review of chemotherapy-induced peripheral neuropathy treatments.Front Pain Res (Lausanne)2025https://conductscience.org/library/papers/40176845PubMed
39507541Molecular and modular intricacies of precision oncology.Front Immunol2024https://conductscience.org/library/papers/39507541PubMed
38784107Advancing regulatory science through real-world data and real-world evidence.J Clin Transl Sci2024https://conductscience.org/library/papers/38784107PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37830006

GET https://conductscience.org/api/papers/v1/37830006/authors